• Home
  • Brenntag Holding GmbH

Brenntag Holding GmbH

About Brenntag Holding GmbH

Brenntag Pharma, part of the Life Science segment within Brenntag Specialties, is the trusted advisor to the pharmaceutical and biopharmaceutical industry with a broad product portfolio and unique value-added services. With its dedicated team of industry experts, Brenntag Pharma creates value for its global business partners through customized repackaging under GMP conditions, warehousing in GDP sites, regulatory support, analytical services and more. It serves various markets, including API Synthesis, Biopharma, Diagnostics, Pharmaceuticals and Nutritional Health.

Read more Show less
Certifications
  • GMP
    GMP
  • ISO
    ISO
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Germany
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    5000+
Company types
Distributor/Import Export
Primary activities
Analytical Services
Biopharmaceutical
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Ingredients Distributor/Buyer
Regulatory Affairs
Supply Chain
Transport/Logistics/Distribution
Contact info
Show contact info Hide contact info
Meet us at

CPHI & PMEC China 2026

Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026
View Exhibitor Profile

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
View Exhibitor Profile

Products from Brenntag Holding GmbH (12)

Brenntag Holding GmbH Resources (4)

  • How Brenntag is approaching the current trends in the biopharma market

    Video How Brenntag is approaching the current trends in the biopharma market

    In this interview with Gearoid O'Rourke, Director Value Added Services Pharma EMEA, for Brenntag speaks about the current trends in the global and European biopharmaceutical industry, and the supplier trends relevant for manufacturers and distributors. Finally O'Rourke covers what trends Brenntag envisages in the future for suppliers to the biopharmaceutical industry.
    2026-02-02
  • CPHI 2025 Frankfurt Interview with Gust Desmedt, President Pharma Global of Brenntag

    Video CPHI 2025 Frankfurt Interview with Gust Desmedt, President Pharma Global of Brenntag

    During the interview Gust Desmedt, President Pharma Global of Brenntag shared his thoughts about: • This year’s Brenntag Pharma motto for CPHI “More than you think” • Brenntag’s main value proposition to pharmaceutical and biopharma customers • How Brenntag uses CPHI to showcase this approach • And looking ahead, what’s next for Brenntag Pharma and what visitors should take away from CPHI
    2026-02-02
  • Brenntag Pharma Project Managers Susana Antunes and Manuel Keune on their guerilla marketing approach at the CPHI 2025 in Frankfurt

    Video Brenntag Pharma Project Managers Susana Antunes and Manuel Keune on their guerilla marketing approach at the CPHI 2025 in Frankfurt

    With this year’s motto “More than you think”, Brenntag Pharma wanted to change the perception the pharma and biopharma industry has of Brenntag. Coming from a commodity distributor world but today deep into the business of APIs, excipients, nutritional health, regulated synthesis, and biopharma as well as GMP-manufacturing and services, Brenntag Pharma needed a new marketing approach to show this to CPHI visitors. Susana and Manuel share what this guerilla marketing campaign looked like.
    2026-02-02
  • Welcome to the future of Value Added Solutions for the Pharma Industry – Discover the Future Sustainable Brenntag!

    Industry Webinar Welcome to the future of Value Added Solutions for the Pharma Industry – Discover the Future Sustainable Brenntag!

    Brenntag developed a long-term strategy and strives for the vision to become a “Future Sustainable Brenntag”. Watch our session and get inspired by Dr. Andreas Kicherer and Wolfgang Edel.
    This session highlights: Innovation meets Sustainability → meet our NEW green products and solutions. Circular economy for API production → our hands-on solution. Brenntag ESG framework → Footprint Reduction and Handprint Increase as a Distribution company.
    Listen to our initiatives and actions to create Value Added Solutions for the Pharma Industry!
    2022-11-15